CLSN - Celsion Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
3.83
-0.25 (-6.13%)
At close: 4:00PM EDT

3.83 0.00 (0.00%)
After hours: 7:57PM EDT

Stock chart is not supported by your current browser
Previous Close4.08
Open4.00
Bid3.55 x 600
Ask4.25 x 2000
Day's Range3.54 - 4.04
52 Week Range0.19 - 6.06
Volume2,751,259
Avg. Volume3,084,383
Market Cap31.99M
Beta1.37
PE Ratio (TTM)-0.69
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube7 days ago

    ETFs with exposure to Celsion Corp. : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cancer Space Last Week Update: Pipeline Expansion in Focus
    Zacks8 days ago

    Cancer Space Last Week Update: Pipeline Expansion in Focus

    Last week, a few companies in the cancer segment entered deals for expanding their portfolio. Another key development was a ruling in favor of a major cancer drug by the U.S. patent office.

  • Celsion's Immunotherapy Candidate Impresses, Stock Surges
    Zacks13 days ago

    Celsion's Immunotherapy Candidate Impresses, Stock Surges

    Celsion's (CLSN) pipeline candidate, GEN1, controls ovarian cancer in all patients in the phase Ib study and achieves a historical improvement in progression free survival.

  • Capital Cube29 days ago

    ETFs with exposure to Celsion Corp. : September 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Stocks Near 52-Week Lows: 4 Attractive Picks
    Zackslast month

    Stocks Near 52-Week Lows: 4 Attractive Picks

    Fundamentally strong stocks trading around their 52-week lows make for a great bargain, despite how weak the broader market considers them right now.

  • Capital Cube2 months ago

    ETFs with exposure to Celsion Corp. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Celsion Corp. :CLSN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
    Capital Cube2 months ago

    Celsion Corp. :CLSN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Celsion Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Celsion Corp. – ArQule, Inc., ImmunoGen, Inc., Endocyte, Inc., Spectrum Pharmaceuticals, Inc., ZIOPHARM Oncology, Inc., Exelixis, Inc. and Keryx Biopharmaceuticals, Inc. (ARQL-US, IMGN-US, ECYT-US, SPPI-US, ZIOP-US, EXEL-US and KERX-US) ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CLSN earnings conference call or presentation 15-Aug-17 3:00pm GMT

    Q2 2017 Celsion Corp Earnings Call

  • Celsion Completes Ovarian Cancer Trial Enrollment, Stock Up
    Zacks3 months ago

    Celsion Completes Ovarian Cancer Trial Enrollment, Stock Up

    Celsion Corp. (CLSN) shares rose after the company has announced completion of enrolment in a phase Ib study, evaluating its immunotherapy, GEN-1 in combination with neoadjuvant chemotherapy for treatment of advanced ovarian cancer.

  • TheStreet.com3 months ago

    This Biotech Stock Is Surging More Than 20% Today

    Here are the names.

  • Capital Cube4 months ago

    ETFs with exposure to Celsion Corp. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to Celsion Corp. : May 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Celsion Corp. :CLSN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017
    Capital Cube5 months ago

    Celsion Corp. :CLSN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Celsion Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Celsion Corp. – Threshold Pharmaceuticals, Inc., ArQule, Inc., Endocyte, Inc., Spectrum Pharmaceuticals, Inc., ZIOPHARM Oncology, Inc., Exelixis, Inc. and Keryx Biopharmaceuticals, Inc. (THLD-US, ARQL-US, ECYT-US, SPPI-US, ZIOP-US, EXEL-US and ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CLSN earnings conference call or presentation 12-May-17 3:00pm GMT

    Q1 2017 Celsion Corp Earnings Call

  • Capital Cube6 months ago

    ETFs with exposure to Celsion Corp. : April 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Celsion Corp. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Celsion Corp. :CLSN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017
    Capital Cube7 months ago

    Celsion Corp. :CLSN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017

    Categories: Yahoo Finance Get free summary analysis Celsion Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Celsion Corp. – Threshold Pharmaceuticals, Inc., ArQule, Inc., ImmunoGen, Inc., Endocyte, Inc., Spectrum Pharmaceuticals, Inc., ZIOPHARM Oncology, Inc., Exelixis, Inc. and Keryx Biopharmaceuticals, Inc. (THLD-US, ARQL-US, IMGN-US, ECYT-US, SPPI-US, ... Read more (Read more...)

  • Forget Gilead, Buy These Small-Cap Biotech Stocks Instead
    Zacks7 months ago

    Forget Gilead, Buy These Small-Cap Biotech Stocks Instead

    At this juncture, we advise investors to forget Gilead (GILD), a Zacks Rank #4 (Sell) stock, and invest in some other small cap biotech stocks (market capitalization below $200 million) that carry an impressive Zacks Rank.

  • Capital Cube9 months ago

    ETFs with exposure to Celsion Corp. : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube11 months ago

    ETFs with exposure to Celsion Corp. : November 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Celsion Corp. Here are 5 ETFs with the largest exposure to CLSN-US. Comparing the performance and risk of Celsion Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)